a framework
play

A framework Crohns disease DM1 Directly related Directly related - PDF document

4/13/2018 Skin signs of endocrine disorders Anna Haemel MD Assistant Professor UCSF Dermatology Skin and systemic disease: A framework Crohns disease DM1 Directly related Directly related (cutaneous Crohns) (scleredema


  1. 4/13/2018 Skin signs of endocrine disorders Anna Haemel MD Assistant Professor UCSF Dermatology Skin and systemic disease: A framework Crohn’s disease DM1 • Directly related • Directly related (cutaneous Crohn’s) (scleredema adultorum) • Reactive condition • Reactive condition (neutrophilic dermatosis) (N/A) • Associated condition • Associated condition (alopecia areata) (dermatitis herpetiformis) • Treatment side effect • Treatment side effect (TNFi induced psoriasis) (insulin injection reaction) 1

  2. 4/13/2018 Overview • Skin manifestations of • Skin manifestations of nonmalignant neoplastic endocrine endocrine d/o incl: conditions incl: – Thyroid – Genetic • Hyper • MEN syndromes • Hypo – Metabolic – Pancreas • Glucagonoma • Diabetes – Paraneoplastic – Androgen excess • Dermatomyositis • PCOS Case 1: Textural changes to legs 2

  3. 4/13/2018 Case 1 Case 1 • 1 year hx of textural changes to shins> upper extremities • Consult question: Does this patient have scleromyxedema? • Skin bx forearm – dermal mucinosis • Labs – SPEP/IFE/free light chains neg 3

  4. 4/13/2018 Case 1 • Prior hx Graves’, incl Graves’ ophthalmopathy – Significant proptosis – Significant ocular surface exposure OD>OS – No signs of optic nerve compromise – Intermittent diplopia that is not bothersome to the patient Graves’ disease Cutaneous Features • Ophthalmopathy (30%) • Pretibial myxedema (4%) • Acropachy (1%) • Stimulation of thyrotropin receptor results in mesenchymal tissue expansion • Correction of thyroid level has no effect on skin lesions Transl Pediatr. 2017 Oct;6(4):300-312. Int J Dermatol. 2015 Aug;54(8):e280-6 4

  5. 4/13/2018 Thyroid Dermopathy Pretibial Myxedema • Accumulation of glycosaminoglycans • Bilateral, localized • Nonpitting infiltration • Nodules and plaques • Elephantiasis-like • Usually have ophthalmopathy • Acropachy is variable Transl Pediatr. 2017 Oct;6(4):300-312. Int J Dermatol. 2015 Aug;54(8):e280-6 Case 1 • Treatment approach – Ophtho consult for thyroid associated orbitopathy: Currently inactive • Encouraged current attempts to quit smoking – Skin directed therapy: • Topical/intralesional triamcinolone • Compression garments orders (sleeves, gloves, stockings) 5

  6. 4/13/2018 Case 1 Relative sparing at sites of compression/straps Thyroid Acropachy • Clubbing • Soft tissue swelling of hands and feet • Periosteal reaction of extremity bones • Thyroid acropachy is associated w severe Graves’ orbitopathy and need for orbital decompression Transl Pediatr. 2017 Oct;6(4):300-312. Int J Dermatol. 2015 Aug;54(8):e280-6 Thyroid. 2003 Dec;13(12):1141-4. 6

  7. 4/13/2018 soft tissue swelling onycholysis Thyroid acropachy: periosteal bone formation at the metacarpophalanges and proximal phalanges N Engl J Med. 2016 Jul 21;375(3):261. 7

  8. 4/13/2018 Hypothyroidism Myxedema = systemic mucinosis • Skin is cold, xerotic, pale • Coarse hair • Loss of outer third of eyebrow = madarosis • Puffy face • Broad nose • Thick lips and large tongue (macroglossia) • Drooping eyelids and periorbital swelling – MPS deposition • Cutis verticis gyrata • Carotenemia  yellow palms and soles Transl Pediatr. 2017 Oct;6(4):300-312. 8

  9. 4/13/2018 Hyperthyroidism • Skin is warm, moist, and smooth • Palmar erythema • Facial flushing • Hair is thinned, downy • Hyperpigmentation • Hyperhidrosis • Nail changes – Plummer nails: concave with distal onycholysis Transl Pediatr. 2017 Oct;6(4):300-312. Int J Dermatol. 2015 Aug;54(8):e280-6 9

  10. 4/13/2018 Hyperthyroidism Other Cutaneous Features • Vitiligo – 7% of patients with Graves’ disease – Increased in patients with Hashimoto's thyroiditis • Urticaria – Check thyroid antibodies in chronic urticaria Transl Pediatr. 2017 Oct;6(4):300-312. 10

  11. 4/13/2018 Case 2: Referral for “morphea” 11

  12. 4/13/2018 Case 2 • Skin bx: thickening of the reticular dermis with a slight increase in the amount of interstitial mucin in the deep dermis • Dx: Scleredema adultorum – Sclerodermiform mucinosis – Glycosylation of proteins Transl Pediatr. 2017 Oct;6(4):300-312. 12

  13. 4/13/2018 Scleredema adultorum • Painless non pitting swelling/induration starting on upper back/neck and can spread to upper torso • 2.5-14% of pts with DM; more common in men • Increased deposition of collagen due to irreversible nonenzymatic glycosylation of collagen/resistance to degradation • Very challenging to treat – PUVA, MTX, IVIG, other… Clin Rev Allergy Immunol. 2017 Dec;53(3):306-336. Skin Signs of diabetes Directly related Associated conditions • Scleredema • Candidiasis • Diabetic • Fungal infections cheiroarthropathy • Diabetic • Necrobiosis lipoidica dermopathy • Granuloma annulare? • Bullous diabeticorum • Psoriasis • Acanthosis nigricans 13

  14. 4/13/2018 • Diabetic dermopathy – Most common cutaneous marker of DM – 70% of adults w DM Transl Pediatr. 2017 Oct;6(4):300-312. • Bullous diabeticorum – Rare but specific (0.05% of pts) – Large noninflammatory monolocular bullae on dorsal foot/ankle Image courtesy of Lindy Fox MD Transl Pediatr. 2017 Oct;6(4):300-312. 14

  15. 4/13/2018 Acanthosis nigricans assoc w insulin resistance • AN is a sign of peripheral insulin resistance • Increased in groups with DM commonly (NA, Hispanics, AA’s) and in obesity • Elevated insulin levels bind to Insulin Growth Factor receptors on keratinocytes causing AN Transl Pediatr. 2017 Oct;6(4):300-312. Skin Signs of diabetes Directly related Associated conditions • Scleredema • Candidiasis • Diabetic • Dermatophytosis cheiroarthropathy • Diabetic dermopathy • Necrobiosis lipoidica • Bullous diabeticorum • Granuloma annulare ? • Acanthosis nigricans • Psoriasis 15

  16. 4/13/2018 16

  17. 4/13/2018 • Necrobiosis lipoidica diabeticorum – 0.3% to 1.6% of pts w DM – BUT 75% of cases of NLD occur in pts who have or will develop DM Case 3: Severe adult female acne • 28 YOF • Acne in teens, now recurrent again in late 20s • Irregular menses, excess hair growth, thinning scalp hair • A1c = 5.8% 17

  18. 4/13/2018 Photo courtesy of Kanade Shinkai MD, PhD PCOS and skin • 72-82% of pts w PCOS have cutaneous signs of hyperandrogenism • Acne - 61% of pts w PCOS – not a reliable marker • Hirsutism – 53% of pts w PCOS – excellent marker • Acanthosis nigricans – 37% of pts w PCOS – excellent marker • Hirsutism and AN are both assoc w elevated free testosterone level and increased insulin resistance Schmidt T et al (2016) JAMA Derm, 152: 391-398 18

  19. 4/13/2018 Hirsutism - a specific sign in PCOS Photo courtesy of Kanade Shinkai MD, PhD Photo courtesy of Kanade Shinkai MD, PhD 19

  20. 4/13/2018 Acanthosis nigricans is specific sign in PCOS Photo courtesy of Kanade Shinkai MD, PhD Androgenetic alopecia - not a reliable marker of PCOS Schmidt T et al (2015) JAMA Derm, Dec 23:1-8 20

  21. 4/13/2018 Treatment • Weight loss • Dietary changes • OCPs • Metformin as needed for hyperglycemia • Spironolactone for hirsutism, acne Dermatology & disorders of androgen excess • PCOS (most common) • CAH • Ovarian tumors • Adrenal tumors 21

  22. 4/13/2018 Case 4 22

  23. 4/13/2018 Necrolytic migratory erythema (assoc w glucagonoma) • Glucagonoma syndrome: NME skin findings, incr glucagon levels, diabetes/glucose intolerance • NME: Migratory plaques w superficial epidermal necrosis, central flaccid bullae, and crusted erosions – Favors flexural areas – Skin may respond to somatostatin analog (octreotide) Int J Dermatol. 2018 Feb 16. 23

  24. 4/13/2018 Skin manifestations of neoplastic endocrine disorders – Metabolic/neuroendocrine • Glucagonoma – Paraneoplastic • Dermatomyositis – Genetic • MEN syndromes Necrolytic migratory erythema (assoc w glucagonoma) • Pathogenesis: metabolic etiology involving excess glucagon, amino acid deficiency, zinc deficiency, and free fatty acid deficiency – Skin may impove w IV amino acid supplementation or zinc – Clinically appears similar to eruption of acrodermatitis enteropathica Int J Dermatol. 2018 Feb 16. 24

  25. 4/13/2018 Skin manifestations of neoplastic endocrine disorders – Metabolic/neuroendocrine • Glucagonoma – Paraneoplastic • Dermatomyositis – Genetic • MEN syndromes 25

  26. 4/13/2018 Malignancy in dermatomyositis • Most studies have found an increased risk of cancer with DM in up to 30% of patients • Ovarian cancer over-represented • Risk is highest in first 2 years , but remains elevated out to 5 years • Disease may improve with cancer treatment Am J Clin Dermatol. 2015 Apr;16(2):89-98. 26

  27. 4/13/2018 Palmar fasciitis - polyarthritis: Assoc w ovarian cancer Clin Exp Dermatol. 2017 Apr;42(3):328-330. Skin manifestations of neoplastic endocrine disorders – Metabolic/neuroendocrine • Glucagonoma – Paraneoplastic • Dermatomyositis – Genetic • MEN syndromes 27

Recommend


More recommend